COMPANY PROFILE

CeloNova

Explore full profile

Innovative medical device coatings enhancing biocompatibility, drug delivery, and healing properties

Carlsbad, United StatesFounded 2000Biotech & Life Sciences

Valuation $50–100M Last recorded · 2011

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About CeloNova

Alta Biomaterials specializes in developing proprietary coating technologies for medical devices, aimed at enhancing biocompatibility, drug delivery, and providing anti-inflammatory, thromboresistant, and pro-healing properties. The company partners with original equipment manufacturers (OEMs) in the medical device industry to co-develop and optimize implant interactions within the body. Operating primarily in the US and European markets, Alta Biomaterials has a strong track record of product development and commercialization. The business model revolves around forming strategic partnerships with medical device manufacturers, leveraging their expertise in PzF applications and other advanced materials to create innovative solutions that improve patient outcomes. Revenue is generated through these partnerships and the commercialization of their proprietary technologies.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2000
Headquarters: Carlsbad, United States
Employees: 37
Open positions: None listed
Dealroom signal: 26.3/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
OtherOther financing	Nov 2018	$0	—	WP Global	—
LATE VC✓Equity / VC	Feb 2011	$21M	$83M	Undisclosed	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

CeloNova website traffic

Latest recorded traffic for CeloNova is 300 monthly website visits, down 54.5% over the last three months. CeloNova's team grew 0% over the past year.

Latest monthly visits300 3-month web change-54.5% 1-year team growth0%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
SESentanteDeveloping a radiation-reducing manipulator and a minimally invasive coronary robotic system for endovascular procedures	Kaunas, Lithuania	Operational	39	$9.1M	$26M
A4A4CellDevelops New technology named SPAchip (Suspended Planar-Array Chips) offering a perfect way to track living single cell	Madrid, Spain	Operational
HSHirotsu Bio ScienceDeveloped N-Nose, a non-invasive cancer screening product using nematode worms to detect early-stage cancers through urine samples	Tokyo, Japan	Operational
NANanoligentThe research and development to clinical phases of innovative cancer treatments based on protein nanoparticles	Cerdanyola del Vallès, Spain	Operational
CACarvolixThe new generation of minimally invasive implants to treat diseases of the heart, aorta, and urinary incontinence	Paris, France	Operational
UDUniversal Medical Imaging DiagnosticOffers a holistic alternative and complementary approach to overall health that uses non-invasive, non-radioactive and painless imaging of the whole body	Los Angeles, United States	Operational
4M4D MedicalImproving global health by providing unique and non-invasive imaging technologies that enable unprecedented insight into pulmonary functioning, critical in the analysis and management of respiratory diseases	Melbourne, Australia	Operational
CECelluminovaSpecializes in the development of new tools for stem cell research, including cancer stem cells	Norrköpings kommun, Sweden	Operational